# T-Mobile US, Inc.: financial statements, quarterly

TMUS · Nasdaq · CIK 1283699 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tmus.md) · [Financials](/companies/tmus/financials.md) · [Filings](/companies/tmus/filings.md) · [Insiders](/companies/tmus/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tmus/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [20.5 d](/filings/0001283699-26-000010.md) | [19.6](/filings/0001283699-25-000079.md) | [19.8](/filings/0001283699-25-000117.md) | [20.2](/filings/0001283699-25-000154.md) | [21.9 d](/filings/0001283699-26-000010.md) | [20.9](/filings/0001283699-26-000063.md) | [21.1](/filings/0001283699-26-000101.md) | [22.0](/filings/0001283699-26-000129.md) | [24.3 d](/filings/0001283699-26-000010.md) | [23.1](/filings/0001283699-26-000063.md) | [22.8](/filings/0001283699-26-000101.md) | [23.6](/filings/0001283699-26-000129.md) |
| Cost of revenue | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $bn | [5.3 d](/filings/0001283699-26-000010.md) | [5.1](/filings/0001283699-25-000079.md) | [5.1](/filings/0001283699-25-000117.md) | [5.2](/filings/0001283699-25-000154.md) | [5.4 d](/filings/0001283699-26-000010.md) | [5.5](/filings/0001283699-26-000063.md) | [5.4](/filings/0001283699-26-000101.md) | [6.0](/filings/0001283699-26-000129.md) | [6.6 d](/filings/0001283699-26-000010.md) | [6.0](/filings/0001283699-26-000063.md) | [5.8](/filings/0001283699-26-000101.md) | [6.0](/filings/0001283699-26-000129.md) |
| Operating income | $bn | [3.5 d](/filings/0001283699-26-000010.md) | [4.0](/filings/0001283699-25-000079.md) | [4.6](/filings/0001283699-25-000117.md) | [4.8](/filings/0001283699-25-000154.md) | [4.6 d](/filings/0001283699-26-000010.md) | [4.8](/filings/0001283699-26-000063.md) | [5.2](/filings/0001283699-26-000101.md) | [4.5](/filings/0001283699-26-000129.md) | [3.7 d](/filings/0001283699-26-000010.md) | [4.5](/filings/0001283699-26-000063.md) | [5.5](/filings/0001283699-26-000101.md) | [5.7](/filings/0001283699-26-000129.md) |
| Interest expense | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $bn | [0.6 d](/filings/0001283699-26-000010.md) | [0.8](/filings/0001283699-25-000079.md) | [0.8](/filings/0001283699-25-000117.md) | [0.9](/filings/0001283699-25-000154.md) | [0.9 d](/filings/0001283699-26-000010.md) | [0.9](/filings/0001283699-26-000063.md) | [1.1](/filings/0001283699-26-000101.md) | [0.8](/filings/0001283699-26-000129.md) | [0.5 d](/filings/0001283699-26-000010.md) | [0.8](/filings/0001283699-26-000063.md) | [1.1](/filings/0001283699-26-000101.md) | [1.1](/filings/0001283699-26-000129.md) |
| Net income | $bn | [2.0 d](/filings/0001283699-26-000010.md) | [2.4](/filings/0001283699-25-000079.md) | [2.9](/filings/0001283699-25-000117.md) | [3.1](/filings/0001283699-25-000154.md) | [3.0 d](/filings/0001283699-26-000010.md) | [3.0](/filings/0001283699-26-000063.md) | [3.2](/filings/0001283699-26-000101.md) | [2.7](/filings/0001283699-26-000129.md) | [2.1 d](/filings/0001283699-26-000010.md) | [2.5](/filings/0001283699-26-000063.md) | [3.2](/filings/0001283699-26-000101.md) | [3.5](/filings/0001283699-26-000129.md) |
| Diluted EPS | $ per share | not reported | [2.00](/filings/0001283699-25-000079.md) | [2.49](/filings/0001283699-25-000117.md) | [2.61](/filings/0001283699-25-000154.md) | not reported | [2.58](/filings/0001283699-26-000063.md) | [2.84](/filings/0001283699-26-000101.md) | [2.41](/filings/0001283699-26-000129.md) | not reported | [2.27](/filings/0001283699-26-000063.md) | [2.99](/filings/0001283699-26-000101.md) | [3.22](/filings/0001283699-26-000129.md) |
| Basic EPS | $ per share | not reported | [2.00](/filings/0001283699-25-000079.md) | [2.50](/filings/0001283699-25-000117.md) | [2.62](/filings/0001283699-25-000154.md) | not reported | [2.59](/filings/0001283699-26-000063.md) | [2.84](/filings/0001283699-26-000101.md) | [2.42](/filings/0001283699-26-000129.md) | not reported | [2.28](/filings/0001283699-26-000063.md) | [2.99](/filings/0001283699-26-000101.md) | [3.23](/filings/0001283699-26-000129.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [5.1](/filings/0001283699-25-000012.md) | [6.7](/filings/0001283699-24-000065.md) | [6.4](/filings/0001283699-24-000111.md) | [9.8](/filings/0001283699-24-000142.md) | [5.4](/filings/0001283699-26-000010.md) | [12.0](/filings/0001283699-25-000079.md) | [10.3](/filings/0001283699-25-000117.md) | [3.3](/filings/0001283699-25-000154.md) | [5.6](/filings/0001283699-26-000129.md) | [3.5](/filings/0001283699-26-000063.md) | [2.8](/filings/0001283699-26-000101.md) | [5.6](/filings/0001283699-26-000129.md) |
| Current assets | $bn | [19.0](/filings/0001283699-25-000012.md) | [19.3](/filings/0001283699-24-000065.md) | [19.3](/filings/0001283699-24-000111.md) | [22.5](/filings/0001283699-24-000142.md) | [18.4](/filings/0001283699-26-000010.md) | [27.4](/filings/0001283699-25-000079.md) | [26.8](/filings/0001283699-25-000117.md) | [21.7](/filings/0001283699-25-000154.md) | [24.5](/filings/0001283699-26-000129.md) | [22.1](/filings/0001283699-26-000063.md) | [21.8](/filings/0001283699-26-000101.md) | [21.8](/filings/0001283699-26-000129.md) |
| Total assets | $bn | [208](/filings/0001283699-25-000012.md) | [206](/filings/0001283699-24-000065.md) | [209](/filings/0001283699-24-000111.md) | [211](/filings/0001283699-24-000142.md) | [208](/filings/0001283699-26-000010.md) | [215](/filings/0001283699-25-000079.md) | [213](/filings/0001283699-25-000117.md) | [217](/filings/0001283699-25-000154.md) | [219](/filings/0001283699-26-000129.md) | [215](/filings/0001283699-26-000063.md) | [214](/filings/0001283699-26-000101.md) | [213](/filings/0001283699-26-000129.md) |
| Current liabilities | $bn | [20.9](/filings/0001283699-25-000012.md) | [20.6](/filings/0001283699-24-000065.md) | [23.0](/filings/0001283699-24-000111.md) | [21.0](/filings/0001283699-24-000142.md) | [20.2](/filings/0001283699-26-000010.md) | [23.6](/filings/0001283699-25-000079.md) | [22.1](/filings/0001283699-25-000117.md) | [24.3](/filings/0001283699-25-000154.md) | [24.5](/filings/0001283699-26-000129.md) | [20.3](/filings/0001283699-26-000063.md) | [23.6](/filings/0001283699-26-000101.md) | [24.0](/filings/0001283699-26-000129.md) |
| Total liabilities | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $bn | [71.4](/filings/0001283699-25-000012.md) | not reported | not reported | not reported | [74.2](/filings/0001283699-26-000010.md) | not reported | not reported | not reported | [81.1](/filings/0001283699-26-000010.md) | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [3.6](/filings/0001283699-25-000012.md) | [5.4](/filings/0001283699-24-000065.md) | [5.9](/filings/0001283699-24-000111.md) | [5.9](/filings/0001283699-24-000142.md) | [4.1](/filings/0001283699-26-000010.md) | [8.2](/filings/0001283699-25-000079.md) | [6.4](/filings/0001283699-25-000117.md) | [6.3](/filings/0001283699-25-000154.md) | [5.1](/filings/0001283699-26-000129.md) | [2.2](/filings/0001283699-26-000063.md) | [6.1](/filings/0001283699-26-000101.md) | [6.3](/filings/0001283699-26-000129.md) |
| Shareholders' equity | $bn | [64.7](/filings/0001283699-26-000010.md) | [62.1](/filings/0001283699-25-000117.md) | [62.6](/filings/0001283699-25-000154.md) | [64.3](/filings/0001283699-25-000154.md) | [61.7](/filings/0001283699-26-000129.md) | [61.1](/filings/0001283699-26-000101.md) | [61.1](/filings/0001283699-26-000129.md) | [60.5](/filings/0001283699-26-000129.md) | [59.2](/filings/0001283699-26-000129.md) | [55.9](/filings/0001283699-26-000101.md) | [56.3](/filings/0001283699-26-000129.md) | [56.3](/filings/0001283699-26-000129.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4,859 d](/filings/0001283699-26-000010.md) | [5,084](/filings/0001283699-25-000079.md) | [5,521](/filings/0001283699-25-000117.md) | [6,139](/filings/0001283699-25-000154.md) | [5,549 d](/filings/0001283699-26-000010.md) | [6,847](/filings/0001283699-26-000063.md) | [6,992](/filings/0001283699-26-000101.md) | [7,457](/filings/0001283699-26-000129.md) | [6,654 d](/filings/0001283699-26-000010.md) | [7,222](/filings/0001283699-26-000063.md) | [7,500](/filings/0001283699-26-000101.md) | [7,341](/filings/0001283699-26-000129.md) |
| Capital expenditure | $m | [1,587 d](/filings/0001283699-26-000010.md) | [2,627](/filings/0001283699-25-000079.md) | [2,040](/filings/0001283699-25-000117.md) | [1,961](/filings/0001283699-25-000154.md) | [2,212 d](/filings/0001283699-26-000010.md) | [2,451](/filings/0001283699-26-000063.md) | [2,396](/filings/0001283699-26-000101.md) | [2,639](/filings/0001283699-26-000129.md) | [2,469 d](/filings/0001283699-26-000010.md) | [2,623](/filings/0001283699-26-000063.md) | [2,703](/filings/0001283699-26-000101.md) | [2,270](/filings/0001283699-26-000129.md) |
| Dividends paid | $m | [747 d](/filings/0001283699-26-000010.md) | [769](/filings/0001283699-25-000079.md) | [759](/filings/0001283699-25-000117.md) | [758](/filings/0001283699-25-000154.md) | [1,014 d](/filings/0001283699-26-000010.md) | [1,003](/filings/0001283699-26-000063.md) | [996](/filings/0001283699-26-000101.md) | [987](/filings/0001283699-26-000129.md) | [1,135 d](/filings/0001283699-26-000010.md) | [1,120](/filings/0001283699-26-000063.md) | [1,101](/filings/0001283699-26-000101.md) | [1,089](/filings/0001283699-26-000129.md) |
| Share repurchases | $m | [2,183 d](/filings/0001283699-26-000010.md) | [3,594](/filings/0001283699-25-000079.md) | [2,387](/filings/0001283699-25-000117.md) | [560](/filings/0001283699-25-000154.md) | [4,687 d](/filings/0001283699-26-000010.md) | [2,494](/filings/0001283699-26-000063.md) | [2,555](/filings/0001283699-26-000101.md) | [2,479](/filings/0001283699-26-000129.md) | [2,446 d](/filings/0001283699-26-000010.md) | [4,826](/filings/0001283699-26-000063.md) | [2,320](/filings/0001283699-26-000101.md) | [2,418](/filings/0001283699-26-000129.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,225](/filings/0001283699-24-000065.md) | [1,196](/filings/0001283699-24-000111.md) | [1,174](/filings/0001283699-24-000142.md) | [1,189](/filings/0001283699-25-000079.md) | [1,172](/filings/0001283699-25-000117.md) | [1,171](/filings/0001283699-25-000154.md) | [1,145](/filings/0001283699-26-000063.md) | [1,135](/filings/0001283699-26-000101.md) | [1,127](/filings/0001283699-26-000129.md) | [1,102](/filings/0001283699-26-000063.md) | [1,082](/filings/0001283699-26-000101.md) | [1,072](/filings/0001283699-26-000129.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,059,272,571 at 2026-10-23, from the cover of the [10-Q filed 2026-10-28](/filings/0001283699-26-000129.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:01 ET. No prices; not investment advice.